Blog / Archives
Market Perks Up on FED Testimony-Rates To Stay Low… Update 1 6/19
Update June 19.. 3:10 p EDT Ten Yr 2.62%, U.S.equities flat,biotech mixed, jobless claims down. Japanese and European equities up. Iraq on front page. GOLD Up $41 Breaks Through Resistance at $1300...
Biotech Recap On a Down Day
NASDAQ Off 0.8% On Disappointing Economic Data and Spiking Crude Islamic militants took major cities in Iraq causing a spike in oil to $106. The energy sector rallied 0.7% with many smaller...
Biotech Stocks Get A Turbo Boost From Idenix Deal
Rally Retraces Correction Up To Mid-Point YTD Up until this week we have focused on large cap biopharmaceuticals because of revenue momentum, fair valuations and earnings. A risk -off sentiment due...
Look For Biotech Rally Today Sparked By Merck $3.9B Acquisition of Idenix… Update-1
Update-1.... 45 Minutes Before the Close 6/9...Risk On Biotech stocks soared today right at the open after news of $3.9B Idenix deal news was out. The XBI was up 5.4% on good volume. The XBI is more...
ASCO Oncology Stocks: Recap and Scoreboard- AGIO, MDVN, SGEN Winners
High Profile Biotechnology Companies with ASCO Presence Investors and traders waited toward the end of the ASCO Annual Meeting week to buy their favorite stocks. The biotech sector overall was...
Clinical Tools and Diagnostic Companies:Financial Metrics 2014 Q1Results
Clinical Diagnostic Stocks Were Hit By Bio-Bubble or Revenue Miss Potential upside in EXAS, NSTG and NEOG all are Rayno Dx and Tools picks. With "momentum trading" days over for now, revenue growth...
ASCO Update #4- No Boost For Oncology Stocks… Update-6/4 MDVN, PCYC, SGEN
Update 6/4 Snap- back rally and big green screen! Update 6/3..... Daily Performance-from list below 9 winners, 12 losers Rayno Biopharmaceutical Picks in bold--- Winners: AGIO, INCY, SGEN, EPZM,...
Rayno Dx and Tools 2014 YTD After OCT. Correction: ABAX EXAS ILMN SQNM …Update 12/24/14
Update 11/24/14 Clinical Diagnostics and Tools Stocks Review Performance YTD and compared to 11/13 YTD Top winners YTD are: EXAS 104%, ILMN 71.4%, ABAX 36.8% Top Losers YTD are: NSTG 16.6%, RGDX...
Very Little Bounce in Biotech as ASCO Approaches… Update 2.. 5/22
Rally Developing-Green Screen Alert If you are underweight large cap biotech add FBT ($76.38) up 2%. Most of our large cap picks are up today: ABBV ALXN, BIIB,GILD,REGN. Reverse pattern from...
Pre-ASCO Watch List #2: ARIA, IMGN, PCYC
Rayno Life Science Focus Stocks: ARIA, IMGN, PCYC Ariad (ARIA) Abstracts Several data presentations will be made for Iclusig (Ponatinib) for leukemias and AP26113 its investigational oral...